Purpose or Objective: Anatomical changes taking place over the course of radiation therapy (RT) result in a difference between planned and delivered dose. For pancreatic cancer, we investigated the robustness of clinical treatment plans by quantifying the dosimetric effects of changes in gas volumes, body contour and interfractional target displacement. In addition, we compared the dosimetric effect of anatomical changes between use of bony anatomy and use of intratumoral fiducial markers for patient positioning.
Purpose or Objective: Anatomical changes taking place over the course of radiation therapy (RT) result in a difference between planned and delivered dose. For pancreatic cancer, we investigated the robustness of clinical treatment plans by quantifying the dosimetric effects of changes in gas volumes, body contour and interfractional target displacement. In addition, we compared the dosimetric effect of anatomical changes between use of bony anatomy and use of intratumoral fiducial markers for patient positioning.
Material and Methods:
Nine pancreatic cancer patients were included who had intratumoral markers for daily cone-beam CT (CBCT)-based position verification. The clinical plans (10 MV; 1 arc VMAT; internal CTV (iCTV) to PTV margin = 10 mm) were used for dose calculation. To enable fraction dose calculations on CBCT, the planning CT was deformably registered to each CBCT (13-15 CBCTs per patient); air volumes visible on the CBCT were copied to the deformed CT. Calculations were done for marker-based registration (as clinically used) and for bony anatomy-based registration. For both methods, doses were rigidly summed to yield the accumulated doses on the planning CT. For each patient, all DVHs were normalized to yield for the planned dose to the PTV: V98% = 95% (100% = 36 Gy). To evaluate target coverage, we defined an iCTV+5mm volume, i.e. the iCTV expanded with a 5 mm margin to account for remaining uncertainties including delineation. We analysed D98%, Dmean and D2% for iCTV+5mm and iCTV and examined DVH differences for duodenum and stomach, the organs at risk closest to the iCTV.
Results:
For the iCTV+5mm, D98% changed from mean 96.3% (range 95.5-97.8%) for the planned dose to 96.7% (96.4-97.0%) for marker-based accumulated dose (Table 1) .
These relatively small differences indicate a limited dosimetric effect from changes in gas and body contour, even though the amount of gas visible on CBCT showed large variations (avg. 166 ml, SD 145 ml). In contrast, D98% decreased to 95.3% (85.8-97.9%) for bony anatomy registration, due to systematic errors inherently associated with bony-anatomy patient positioning. Changes for stomach and duodenum depended strongly on the direction of these errors, with large increases in D2% for some (error in direction of organ) and large decreases for others. Differences were largest for the stomach (e.g. D2% from 72.7% (planned) to 82.4% (bony anatomy-based accumulated)). For marker-based positioning, the dosimetric effects for stomach and duodenum were limited (<0.5 Gy in 8 out of 9 patients).
Conclusion:
Photon irradiation of pancreatic tumours is robust to variations in body contour and gastrointestinal gas, with dose coverage only mildly affected by these anatomical changes. However, when using bony anatomy for patient positioning, dose coverage declines due to interfractional tumour position variations. Therefore, the use of fiducial marker-based daily position verification is essential in RT for pancreatic cancer. Patients undergoing prostate intensity modulated arc therapy (IMAT) were retrospectively investigated using the CBCT images acquired for setup purposes to determine the volumetric variability of the target and organs at risk and the dosimetric implications of these changes.
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Material and Methods:
IMAT plans from 11 patients were designed to deliver 74 Gy in 37 fractions to the target. The CTV consisted of the prostate and seminal vesicles, while the PTV was the CTV plus a margin of 10 mm in all directions except posteriorly, where a 5 mm margin was used. For between 9 and 14 of the 37 fractions, the patients were scanned using an on-board CBCT imager to verify the setup. These images were retrospectively registered to the planning CT using an in-house registration algorithm to determine the transformations between the images. The calculated transformation vector field was used to deform the planning CT so that the plan could be recalculated with the original MU on this new adapted CT. This allowed the determination of the dosimetric impact of the change in anatomical information from the time of acquisition of the planning CT to immediately prior to a given treatment fraction. The imaged fractions were treated as though they were representative of the entire treatment and were weighted equally for dose accumulation purposes.
Results: Over the course of the patients' treatments, the changes in CTV volume compared to the plan were from a decrease of 25% up to a maximum increase of 6%. Their bladder volumes ranged from -10% to 10% of their respective volumes on the planning CT. The rectal volume decreased for all patients, with 5% less than the planning volume the smallest reduction and 34% being the largest volume shrinkage. The dosimetric impact of these anatomical changes varied for each structure. The minimum dose received by the CTV varied by less than 1% for all patients, with full coverage of the CTV achieved in all fractions. The mean dose delivered to the bladder averaged over each patients treatment resulted in variation of between -4% and 17% of their respective planned mean doses. This did not result in a break of the dose-volume constraints (DVCs) for the bladder at any fraction, for any patient. The rectum received a higher mean dose than the planned value for all patients. This ranged from an increase of 7% up to 38%. It was found that the rectum frequently broke multiple DVCs, resulting in the rectum being overdosed in 79% of the fractions examined.
Conclusion:
Analysis of the anatomical condition of the patient on the day of treatment can give an indication of how suitable the original plan for their treatment is. For these patients, although the variability in the anatomy did not
